133 related articles for article (PubMed ID: 2144872)
1. Atrial natriuretic peptides inhibit the release of corticotrophin-releasing factor-41 from the rat hypothalamus in vitro.
Ibanez-Santos J; Tsagarakis S; Rees LH; Besser GM; Grossman A
J Endocrinol; 1990 Aug; 126(2):223-8. PubMed ID: 2144872
[TBL] [Abstract][Full Text] [Related]
2. Blockage of K+ channels reverses the inhibitory action of atriopeptin on secretagogue-stimulated ACTH release by perifused isolated rat anterior pituitary cells.
Antoni FA; Dayanithi G
J Endocrinol; 1990 Aug; 126(2):183-91. PubMed ID: 2169519
[TBL] [Abstract][Full Text] [Related]
3. Effect of atrial natriuretic peptide on acetylcholine-induced release of corticotropin-releasing factor from rat hypothalamus in vitro.
Takao T; Hashimoto K; Ota Z
Life Sci; 1988; 42(12):1199-203. PubMed ID: 2964553
[TBL] [Abstract][Full Text] [Related]
4. Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro.
Hillhouse EW; Milton NG
J Endocrinol; 1989 Sep; 122(3):713-8. PubMed ID: 2572662
[TBL] [Abstract][Full Text] [Related]
5. Effect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro.
Hillhouse EW; Milton NG
J Endocrinol; 1989 Sep; 122(3):719-23. PubMed ID: 2809479
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects.
Ur E; Faria M; Tsagarakis S; Anderson JV; Besser GM; Grossman A
J Endocrinol; 1991 Oct; 131(1):163-7. PubMed ID: 1660514
[TBL] [Abstract][Full Text] [Related]
7. Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticotrophin-releasing hormone and pituitary ACTH release in vitro.
Calogero AE; Raiti F; Nicolosi G; Burrello N; D'Agata R; Mantero F
J Endocrinol; 1994 Mar; 140(3):419-24. PubMed ID: 8182369
[TBL] [Abstract][Full Text] [Related]
8. Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro.
Tsagarakis S; Navarra P; Rees LH; Besser M; Grossman A; Navara P
Endocrinology; 1989 May; 124(5):2330-5. PubMed ID: 2539975
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission.
Tringali G; Aubry JM; Moscianese K; Zamori C; Vairano M; Preziosi P; Navarra P; Pozzoli G
J Psychiatry Neurosci; 2004 Nov; 29(6):459-66. PubMed ID: 15644987
[TBL] [Abstract][Full Text] [Related]
10. Effect of corticotropin releasing factor on atrial natriuretic peptide release from the isolated perfused rat heart.
Haug C; Grunt M; Schmid S; Steinbach G; Metzele A; Maier V; Keck FS; Grünert A
Arzneimittelforschung; 1994 May; 44(5):579-82. PubMed ID: 8024626
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus.
Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR
Neuroendocrinology; 2002 Aug; 76(2):70-8. PubMed ID: 12169768
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus.
Tsagarakis S; Gillies G; Rees LH; Besser M; Grossman A
Neuroendocrinology; 1989 Jan; 49(1):98-101. PubMed ID: 2785660
[TBL] [Abstract][Full Text] [Related]
14. The effects of atrial natriuretic peptide (ANP1-28) on corticotropin releasing factor in brain of rats.
Biró E; Gardi J; Vecsernyés M; Julesz J; Tóth G; Telegdy G
Life Sci; 1996; 59(16):1351-6. PubMed ID: 8876664
[TBL] [Abstract][Full Text] [Related]
15. In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus.
Suda T; Yajima F; Tomori N; Demura H; Shizume K
Life Sci; 1985 Oct; 37(16):1499-505. PubMed ID: 2995748
[TBL] [Abstract][Full Text] [Related]
16. Involvement of rat corticotrophin-releasing factor-41-related peptide and vasopressin in adrenocorticotrophin-releasing activity from superfused rat hypothalami in vitro.
Gillies G; Puri A; Hodgkinson S; Lowry PJ
J Endocrinol; 1984 Oct; 103(1):25-9. PubMed ID: 6090571
[TBL] [Abstract][Full Text] [Related]
17. Biphasic inhibition of bioactive hypothalamic corticotrophin releasing factor secretion in vitro by corticosterone and prevention of the second phase by various steroids.
Beckford U; Holmes MC; Gillham B; Jones MT
J Endocrinol; 1983 Jun; 97(3):339-46. PubMed ID: 6602859
[TBL] [Abstract][Full Text] [Related]
18. Stimulatory effect of acetylcholine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.
Suda T; Yajima F; Tomori N; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
Life Sci; 1987 Feb; 40(7):673-7. PubMed ID: 3492648
[TBL] [Abstract][Full Text] [Related]
19. Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro.
Nakagami Y; Suda T; Yajima F; Ushiyama T; Tomori N; Sumitomo T; Demura H; Shizume K
Brain Res; 1986 Oct; 386(1-2):232-6. PubMed ID: 3022879
[TBL] [Abstract][Full Text] [Related]
20. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men.
Bierwolf C; Burgemeister A; Lüthke K; Born J; Fehm HL
J Clin Endocrinol Metab; 1998 Apr; 83(4):1151-7. PubMed ID: 9543132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
